Deadline: January 7, 2028

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. Offered by National Institutes of Health; applications due January 7, 2028.

Key Facts

Funder
National Institutes of Health
Award amount
Not specified by funder
Deadline
January 7, 2028
Geography
United States
Categories
Research
Status
Open

About This Grant

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

Full requirements and application instructions: official listing.

Similar Open Grants

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.